| 000 | 01286 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516024320.0 | ||
| 264 | 0 | _c20110818 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1534-6269 | ||
| 024 | 7 |
_a10.1007/s11912-011-0160-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAljumaily, Raid | |
| 245 | 0 | 0 |
_aOptimal management of bone metastases in prostate cancer. _h[electronic resource] |
| 260 |
_bCurrent oncology reports _cJun 2011 |
||
| 300 |
_a222-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAndrostenes |
| 650 | 0 | 4 |
_aAndrostenols _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aRANK Ligand _xgenetics |
| 650 | 0 | 4 |
_aTaxoids _xtherapeutic use |
| 650 | 0 | 4 |
_aTissue Extracts _xtherapeutic use |
| 700 | 1 | _aMathew, Paul | |
| 773 | 0 |
_tCurrent oncology reports _gvol. 13 _gno. 3 _gp. 222-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11912-011-0160-5 _zAvailable from publisher's website |
| 999 |
_c20613041 _d20613041 |
||